Alastair Donald
AiCuris (Germany)(DE)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, HIV/AIDS drug development and treatment, Histone Deacetylase Inhibitors Research, Protein Degradation and Inhibitors
Most-Cited Works
- → Identification of 4-(4-Aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as Selective Inhibitors of Protein Kinase B through Fragment Elaboration(2008)99 cited
- → Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor(2010)83 cited
- → Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs(2011)69 cited
- → Rapid Evolution of 6-Phenylpurine Inhibitors of Protein Kinase B through Structure-Based Design(2007)65 cited
- → Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B(2005)37 cited
- → A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2(2020)32 cited
- → HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo(2015)30 cited
- → Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases(2010)6 cited
- → Discovery of AIC263282, a Hepatitis B Virus Capsid Assembly Modulator Ready for Candidate Profiling(2025)3 cited
- → Structure-based Design of Novel Hepatitis B Virus Capsid Assembly Modulators(2023)2 cited